Correspondence 0001193125-25-005303 from Olema Pharmaceuticals, Inc. (OLMA) (CIK 0001750284) (OLMA)
Olema Pharmaceuticals, Inc. (OLMA) (CIK 0001750284)
Date: Jan. 13, 2025 · CIK: 0001750284 · Accession: 0001193125-25-005303
AI Filing Summary & Sentiment
File numbers found in text: 333-284146
Letter
OLEMA PHARMACEUTICALS, INC.
780 Brannan Street
San Francisco, California 94103
January 13, 2025
VIA EDGAR
Securities and Exchange Commission
Office of Finance
Division of Corporation Finance
100 F. Street N.E.
Washington, D.C. 20549-3010
RE: Olema Pharmaceuticals, Inc.
Registration Statement on Form S-3 (File No. 333-284146)
Request for Acceleration of Effective Date
Ladies and Gentlemen:
Olema Pharmaceuticals, Inc. (the “Registrant”) hereby requests that the U.S. Securities and Exchange Commission (the “Commission”) take appropriate action to cause the above-referenced Registration Statement on Form S-3 (File No. 333-284146) (the “Registration Statement”) to become effective on Wednesday, January 15, 2025, at 4:30 p.m., Eastern Time, or as soon thereafter as is practicable or at such later time as the Registrant may orally request via telephone call to the staff of the Commission. The Registrant hereby authorizes each of Jodie Bourdet and Julia Boesch of Cooley LLP, counsel to the Registrant, to make such request on its behalf.
Once the Registration Statement has been declared effective, please orally confirm that event with Jodie Bourdet of Cooley LLP, counsel to the Registrant, at (415) 693-2054, or in her absence, Julia Boesch at (415) 693-2326.
[Remainder of page intentionally left blank]
Very truly yours,
OLEMA PHARMACEUTICALS, INC.
Show Raw Text
CORRESP 1 filename1.htm CORRESP OLEMA PHARMACEUTICALS, INC. 780 Brannan Street San Francisco, California 94103 January 13, 2025 VIA EDGAR Securities and Exchange Commission Office of Finance Division of Corporation Finance 100 F. Street N.E. Washington, D.C. 20549-3010 RE: Olema Pharmaceuticals, Inc. Registration Statement on Form S-3 (File No. 333-284146) Request for Acceleration of Effective Date Ladies and Gentlemen: Olema Pharmaceuticals, Inc. (the “Registrant”) hereby requests that the U.S. Securities and Exchange Commission (the “Commission”) take appropriate action to cause the above-referenced Registration Statement on Form S-3 (File No. 333-284146) (the “Registration Statement”) to become effective on Wednesday, January 15, 2025, at 4:30 p.m., Eastern Time, or as soon thereafter as is practicable or at such later time as the Registrant may orally request via telephone call to the staff of the Commission. The Registrant hereby authorizes each of Jodie Bourdet and Julia Boesch of Cooley LLP, counsel to the Registrant, to make such request on its behalf. Once the Registration Statement has been declared effective, please orally confirm that event with Jodie Bourdet of Cooley LLP, counsel to the Registrant, at (415) 693-2054, or in her absence, Julia Boesch at (415) 693-2326. [Remainder of page intentionally left blank] Very truly yours, OLEMA PHARMACEUTICALS, INC. By: /s/ Shane Kovacs Name: Shane Kovacs Title: Chief Operating and Financial Officer cc: Jodie Bourdet, Cooley LLP Kristin VanderPas, Cooley LLP Julia Boesch, Cooley LLP